METAURUS EQUITY COMPONENT TR
US EQT EX 2027 · CUSIP 59140L209
3
institutional holders
+0 vs Q1 2020
201.1k
shares reported held*
$13.5mreported value*
0 new
0 added
1 reduced
0 sold out
net sold ≈ $30.0k (-447 shares)
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Implied quarter-end price ≈ $67.05.
Trends to Q2 2020
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q4 2019 | 4 |
| Q1 2020 | 3 |
| Q2 2020 | 3 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Bought or addedCut or sold out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q1 2020 | 1 | 1 |
| Q2 2020 | 0 | 1 |
Biggest buyers
| None |
Biggest sellers
| UBS Group AG | Reduced | -447 |
Holders, Q2 2020
| Manager | Shares | Change |
|---|---|---|
| Fore Capital, LLC 17.18% of their portfolio | 200.0k $13.4m | Unchanged |
| UBS Group AG 0.00% of their portfolio | 1.1k $74.0k | Reduced -447 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |